CTRI/2018/07/014808已完成4 期
EVALUATION OF THE EFFICACY AND IN USE TOLERANCE OF A SKIN ANTI AGEING NUTRACEUTICAL PRODUCT IN WOME
Axys Nutrition Products Pvt Ltd0 个研究点目标入组 34 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 34
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Voluntary women with mild to moderate wrinkles.
- •- Having at least 1 hyperpigmented spot.
- •- Having undereye dark circles.
- •- Food habit - Non-vegetarians or consented vegetarian.
- •- Subjects not on any nutritional supplement or not consuming any therapeutic medication for any disorder for last 45 days.
排除标准
- •- Subjects with any chronic illness or any clinical condition.
- •- Subjects showing abnormal levels in blood test parameters.
- •- Pregnant Women (as confirmed via UPT) and lactating women.
- •- Subject likely to undergo any surgery in the period of the study.
- •- Subjects who have used a collagen peptide containing supplement in the past 6 months.
- •- Subjects consuming tobacco.
- •- Obese individuals (BMI >30).
研究者
相似试验
已完成
不适用
To study the effect and safety of an Anti-acne creamCTRI/2022/09/045553PhytoMyco Research Pvt Ltd33
已完成
不适用
To study the effect of a product on wrinkles in volunteers.CTRI/2022/10/046168Zywie Ventures Pvt. Ltd.
进行中（未招募）
不适用
Evaluation of the effectiveness and the tollerability of paracetamol 1000 mgs + caffeine 130 mgs in the treatment of the migraine. I study randomizzato, double blind, double dummy, vs. sumatriptan 50 mgs and placebo - NDPatients will be enlisted you cut from migraine with and without aura (codes 1.1 and 1.2.1, according to the criterions defined by the International Classification ICH2 of the 2004)MedDRA version: 9.1Level: HLGTClassification code 10019231EUCTR2010-019083-36-IT.O. Tossicologia
进行中（未招募）
1 期
Investigation of the effectiveness, tolerability and safety of ilon® Salbe classic in the treatment of acute inflammation of the hair follicleAcute folliculitisEUCTR2016-005105-39-DECesra Arzneimittel GmbH & Co.KG130
已完成
不适用
An Investigational Drug Co-Administered With Insulin in Patients With Type 2 DiabetesPER-046-05MERCK & CO.INC., BRISTOL MYERS SQUIBB COMPANY,